Nucleai nabs $6.5m Series A

Nucleai, a provider of a AI-powered precision oncology technology, has raised $6.5 million in Series A funding.

7 July 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Technology Briefs